Been thinking about this since the Levin/Pio-Lopez discussion went around the longevity sub last week. Levin’s bioelectric framework for cancer, where malignant cells lose tissue-level coordination and revert to something like single-cell behavior, is worth the read on its own. But it sent me sideways to a question I haven’t seen anyone ask cleanly about epitalon: does injection timing actually matter? The proposed mechanism runs through the pineal gland, melatonin regulation, and downstream telomerase activation. That’s not a mechanism you can treat as timing-neutral. Melatonin secretion is tightly circadian, peaking around 2-3am in most people and suppressed during daylight. If epitalon is genuinely working through pineal regulation, dosing at 10am is mechanistically different from dosing at 9pm. Not marginally different. Different in kind. The half-life problem makes this harder to resolve. Epitalon is a tetrapeptide, half-life is short, probably a few hours subq, faster IM. A morning injection is likely cleared well before the natural melatonin window opens. Whether that matters depends on whether you need concurrent receptor presence or whether a priming effect persists downstream. I don’t know which it is, and I’ve not seen anyone who does. Most protocols I’ve encountered, the standard 10-20 day once-daily cycles, say nothing abt timing. That’s a real gap if the circadian angle holds. I’m not running epitalon and not recommending it. But if the mechanism is what’s claimed, the timing question changes what a valid protocol even looks like. Clean way to test it: same dose, same cycle length, two blocks, morning vs. evening, check whether any effect markers track the timing. That’s not complicated to set up. It’s just not being done